Abstract
Cancer stem cells (CSCs) are affected by the local micro-environment, the niche, in which inflammatory stimuli and hypoxia act as steering factors. Here, two nuclear receptors (NRs) agonists, i.e. pioglitazone (PGZ), a ligand of peroxisome proliferator activated receptor-γ, and 6-OH-11-O-hydroxyphenanthrene (IIF), a ligand of retinoid X receptors, were investigated for their capability to interference with the cross-talk between breast CSCs and the niche compartment. We found that IIF potentiates the ability of PGZ to hamper the mammospheres-forming capability of human breast tumours and MCF7 cancer cells, reducing the expression of CSCs regulatory genes (Notch3, Jagged1, SLUG, Interleukin-6, Apolipoprotein E, Hypoxia inducible factor-1α and Carbonic anhydrase IX). Notably, these effects are not observed in normal-MS obtained from human breast tissue. Importantly, NRs agonists abolish the capability of hypoxic MCF7 derived exosomes to induce a pro-inflammatory phenotype in mammary glands fibroblasts. Moreover, NRs agonist also directly acts on breast tumour associated fibroblasts to downregulate nuclear factor-κB pathway and metalloproteinases (MMP2 and MMP9) expression and activity. In conclusion, NRs agonists disrupt the inflammatory cross-talk of the hypoxic breast CSCs niche.
© 2014 Wiley Periodicals, Inc.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antigens, Neoplasm / metabolism
-
Apolipoproteins E / metabolism
-
Biomarkers, Tumor / metabolism
-
Breast Neoplasms / enzymology
-
Breast Neoplasms / pathology*
-
Carbonic Anhydrase IX
-
Carbonic Anhydrases / metabolism
-
Cell Hypoxia / drug effects
-
Cell Survival / drug effects
-
Exosomes / drug effects
-
Exosomes / metabolism
-
Female
-
Fibroblasts / drug effects
-
Fibroblasts / metabolism
-
Fibroblasts / pathology
-
Humans
-
Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
-
Inflammation / metabolism
-
Inflammation / pathology*
-
Ligands
-
MCF-7 Cells
-
Matrix Metalloproteinase 9 / metabolism
-
Models, Biological
-
NF-kappa B / metabolism
-
Neoplastic Stem Cells / drug effects
-
Neoplastic Stem Cells / enzymology
-
Neoplastic Stem Cells / pathology*
-
PPAR gamma / metabolism*
-
Phenanthrenes / pharmacology
-
Pioglitazone
-
Receptor Cross-Talk* / drug effects
-
Retinoid X Receptors / agonists
-
Retinoid X Receptors / metabolism*
-
Spheroids, Cellular / drug effects
-
Spheroids, Cellular / pathology
-
Stem Cell Niche* / drug effects
-
Stromal Cells / drug effects
-
Stromal Cells / metabolism
-
Stromal Cells / pathology
-
Thiazolidinediones / pharmacology
Substances
-
6-OH-11-O-hydroxyphenanthrene
-
Antigens, Neoplasm
-
Apolipoproteins E
-
Biomarkers, Tumor
-
HIF1A protein, human
-
Hypoxia-Inducible Factor 1, alpha Subunit
-
Ligands
-
NF-kappa B
-
PPAR gamma
-
Phenanthrenes
-
Retinoid X Receptors
-
Thiazolidinediones
-
MMP9 protein, human
-
Matrix Metalloproteinase 9
-
CA9 protein, human
-
Carbonic Anhydrase IX
-
Carbonic Anhydrases
-
Pioglitazone